Experimental procedures were as described in Figure 4.

Results using the C6 glioblastoma cell line are the same as those presented in Figure 4.

AVAS12 is a nonblocking mAb to mVEGFR-2.

Each value represents mean ± SEM of 8 mice for the PBS-treated group and 4 mice for other groups.

P < .01.